Provided by Tiger Trade Technology Pte. Ltd.

Arvinas Holding Company LLC

10.87
-0.0500-0.46%
Pre-market: 10.900.0300+0.28%08:02 EDT
Volume:416.28K
Turnover:4.54M
Market Cap:698.12M
PE:-9.54
High:11.22
Open:10.84
Low:10.71
Close:10.92
52wk High:14.51
52wk Low:5.90
Shares:64.22M
Float Shares:64.22M
Volume Ratio:0.37
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1396
EPS(LYR):-1.1400
ROE:-16.23%
ROA:-7.94%
PB:1.61
PE(LYR):-9.54

Loading ...

Arvinas Reports Positive Phase 1 Data and Advances Pipeline in Q3 2025 Update

Reuters
·
Nov 05, 2025

BRIEF-Arvinas Q3 Revenue USD 41.9 Million

Reuters
·
Nov 05, 2025

Arvinas Q3 Operating Expenses USD 85.7 Million

THOMSON REUTERS
·
Nov 05, 2025

Arvinas Inc: Q3 EPS $-0.48

THOMSON REUTERS
·
Nov 05, 2025

Arvinas Reports Third Quarter 2025 Financial Results and Provides Corporate Update

THOMSON REUTERS
·
Nov 05, 2025

Top News Today: Stocks Slide as Artificial Intelligence Optimism Cools

Dow Jones
·
Nov 05, 2025

Arvinas to Present Preclinical Data for ARV-393 at 2025 ASH Annual Meeting

Reuters
·
Nov 04, 2025

Arvinas Inc expected to post a loss of 79 cents a share - Earnings Preview

Reuters
·
Nov 03, 2025

Arvinas Inc. to Present at Guggenheim Healthcare Innovation Conference

Reuters
·
Nov 03, 2025

Arvinas Is Maintained at Buy by BTIG

Dow Jones
·
Oct 30, 2025

Arvinas presents preclinical data for ARV-806

TIPRANKS
·
Oct 25, 2025

Arvinas Unveils Promising Phase 1 Trial Data for KRAS G12D Degrader ARV-806 in Solid Tumors

Reuters
·
Oct 25, 2025

Arvinas to Present Preclinical Data on ARV-806 KRAS G12D Degrader at 2025 AACR-NCI-EORTC Conference

Reuters
·
Oct 23, 2025

Arvinas announces new patient-reported outcomes data from VERITAC-2 trial

TIPRANKS
·
Oct 20, 2025

Goldman Sachs Downgrades Arvinas to Sell From Neutral, Cuts Price Target to $6 From $8

MT Newswires Live
·
Oct 15, 2025

Arvinas to Present New Phase 3 and Phase 2 Vepdegestrant Clinical Trial Data at 2025 ESMO Congress

Reuters
·
Oct 13, 2025

Piper Sandler Sticks to Their Buy Rating for Arvinas Holding Company (ARVN)

TIPRANKS
·
Oct 07, 2025

Arvinas price target raised to $12 from $10 at BofA

TIPRANKS
·
Oct 07, 2025

Citi Sticks to Its Hold Rating for Arvinas Holding Company (ARVN)

TIPRANKS
·
Oct 07, 2025

U.S. RESEARCH ROUNDUP-BlackRock, Goldman Sachs, Netflix

Reuters
·
Oct 07, 2025